All In Biotech

Drug Trial Radar · NCT04437511

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease

Last checked: Nov 20, 2026Latest source record: Aug 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,736 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

1,736

Actual

Start

Jun 19, 2020

Primary completion

Apr 14, 2023

Study completion Nov 2028

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Jun 18, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 60 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease. Additional participants will be enrolled to an addendum safety cohort. The participants will be administered open-label donanemab. Trial participants who were dosed with donanemab in the main study will be enrolled to a 3-year follow up addendum. No study drug will be administered during this follow up.

Conditions

  • Alzheimer Disease

Interventions

  • DonanemabDrug

    Given IV

  • PlaceboDrug

    Given IV

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline on the Integrated Alzheimer's Disease Rating Scale (iADRS) (Overall Population)Time frame: Baseline, Week 76
  2. Change From Baseline on the Integrated Alzheimer's Disease Rating Scale (iADRS) (Intermediate (Low-medium) Tau Population)Time frame: Baseline, Week 76

Locations

274 sites in 9 countries. Site status is shown where the registry gives one.

  • Gilbert Neurology

    Gilbert, Arizona

  • Xenoscience

    Phoenix, Arizona

  • Banner Alzheimer's Institute

    Phoenix, Arizona

  • Perseverance Research Center

    Scottsdale, Arizona

  • Banner Sun Health Research Institute

    Sun City, Arizona

  • Banner Alzheimer's Institute Tucson

    Tucson, Arizona

  • Center for Neurosciences

    Tucson, Arizona

  • Health Initiatives Research

    Fayetteville, Arkansas

  • North County Neurology Associates

    Carlsbad, California

  • Wr- Pri, Llc

    Encino, California

  • Neuro-Pain Medical Center

    Fresno, California

  • Neurology Center of North Orange County

    Fullerton, California

  • Irvine Clinical Research

    Irvine, California

  • Kaizen Brain Center

    La Jolla, California

  • Senior Clinical Trials, Inc.

    Laguna Hills, California

  • Collaborative Neuroscience Research, LLC

    Los Alamitos, California

  • USC Keck School of Medicine

    Los Angeles, California

  • Clinical Research Institute

    Los Angeles, California

  • Neurovations

    Napa, California

  • Hoag Memorial Hospital Presbyterian

    Newport Beach, California

  • Stanford Neuroscience Health Center

    Palo Alto, California

  • SC3 Research - Pasadena

    Pasadena, California

  • PCND Neurology

    Poway, California

  • Anderson Clinical Research

    Redlands, California

  • Artemis Institute for Clinical Research

    San Diego, California

  • Pacific Research Network

    San Diego, California

  • Sharp Neurocognitive Research Center

    San Diego, California

  • UCSF Memory and Aging Center

    San Francisco, California

  • Syrentis Clinical Research

    Santa Ana, California

  • California Neuroscience Research Medical Group, Inc.

    Sherman Oaks, California

  • Tilda Research

    Tustin, California

  • Mountain Neurological Research Center

    Basalt, Colorado

  • Alpine Clinical Research Center

    Boulder, Colorado

  • Colorado Springs Neurological Associates

    Colorado Springs, Colorado

  • Colorado Neurological Research Center, PC

    Denver, Colorado

  • Institute for Neurodegenerative Disorders

    New Haven, Connecticut

  • Yale University, Alzheimer's Disease Research Unit

    New Haven, Connecticut

  • Research Center for Clinical Studies

    Norwalk, Connecticut

  • Ki Health Partners, LLc, dba New England Institute for Clinical Research

    Stamford, Connecticut

  • Georgetown University Medical Center

    Washington D.C., District of Columbia

Showing 40 of 274 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.